161 related articles for article (PubMed ID: 29507798)
1. The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.
Bertoglio P; Aprile V; Ambrogi MC; Mussi A; Lucchi M
J Thorac Dis; 2018 Jan; 10(Suppl 2):S293-S297. PubMed ID: 29507798
[TBL] [Abstract][Full Text] [Related]
2. Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma.
Choi AY; Singh A; Wang D; Pittala K; Hoang CD
Front Oncol; 2022; 12():886430. PubMed ID: 35586499
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma.
Okabe K
Ann Transl Med; 2017 Jun; 5(11):233. PubMed ID: 28706901
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative adjuncts for malignant pleural mesothelioma.
Chan WH; Sugarbaker DJ; Burt BM
Transl Lung Cancer Res; 2017 Jun; 6(3):285-294. PubMed ID: 28713674
[TBL] [Abstract][Full Text] [Related]
5. Surgery for malignant pleural mesothelioma: an international guidelines review.
Ricciardi S; Cardillo G; Zirafa CC; Carleo F; Facciolo F; Fontanini G; Mutti L; Melfi F
J Thorac Dis; 2018 Jan; 10(Suppl 2):S285-S292. PubMed ID: 29507797
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma.
Friedberg JS
Semin Thorac Cardiovasc Surg; 2009; 21(2):177-87. PubMed ID: 19822291
[TBL] [Abstract][Full Text] [Related]
7. The state of the art in the technical performance of lung-sparing operations for malignant pleural mesothelioma.
Friedberg JS
Semin Thorac Cardiovasc Surg; 2013; 25(2):125-43. PubMed ID: 24216529
[TBL] [Abstract][Full Text] [Related]
8. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma.
Opitz I; Krueger T; Pan Y; Altermatt HJ; Wagnières G; Ris HB
Eur Surg Res; 2006; 38(3):333-9. PubMed ID: 16785733
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma.
Ris HB
Lung Cancer; 2005 Jul; 49 Suppl 1():S65-8. PubMed ID: 15916831
[TBL] [Abstract][Full Text] [Related]
10. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma.
Pass HI; Temeck BK; Kranda K; Thomas G; Russo A; Smith P; Friauf W; Steinberg SM
Ann Surg Oncol; 1997 Dec; 4(8):628-33. PubMed ID: 9416409
[TBL] [Abstract][Full Text] [Related]
11. Treatment of malignant mesothelioma.
Jaklitsch MT; Grondin SC; Sugarbaker DJ
World J Surg; 2001 Feb; 25(2):210-7. PubMed ID: 11338024
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
13. Malignant pleural mesothelioma.
Ho L; Sugarbaker DJ; Skarin AT
Cancer Treat Res; 2001; 105():327-73. PubMed ID: 11224994
[TBL] [Abstract][Full Text] [Related]
14. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
15. A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy.
Davis RW; Papasavvas E; Klampatsa A; Putt M; Montaner LJ; Culligan MJ; McNulty S; Friedberg JS; Simone CB; Singhal S; Albelda SM; Cengel KA; Busch TM
Lasers Surg Med; 2018 Jul; 50(5):440-450. PubMed ID: 29799130
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group.
Rice D; Rusch V; Pass H; Asamura H; Nakano T; Edwards J; Giroux DJ; Hasegawa S; Kernstine KH; Waller D; Rami-Porta R;
J Thorac Oncol; 2011 Aug; 6(8):1304-12. PubMed ID: 21847060
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies for resectable malignant pleural mesothelioma].
Hasegawa S
Nihon Geka Gakkai Zasshi; 2009 Nov; 110(6):338-42. PubMed ID: 19999568
[TBL] [Abstract][Full Text] [Related]
18. Management options for malignant pleural mesothelioma: clinical and cost considerations.
Goudar RK
Drugs; 2007; 67(8):1149-65. PubMed ID: 17521217
[TBL] [Abstract][Full Text] [Related]
19. Surgery for malignant pleural mesothelioma: why, when and what?
Lang-Lazdunski L
Lung Cancer; 2014 May; 84(2):103-9. PubMed ID: 24602395
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary treatment of malignant pleural mesothelioma.
Ceresoli GL; Gridelli C; Santoro A
Oncologist; 2007 Jul; 12(7):850-63. PubMed ID: 17673616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
